MARKET

MRNA

MRNA

Moderna
NASDAQ
33.47
-2.07
-5.81%
Opening 10:56 02/24 EST
OPEN
33.92
PREV CLOSE
35.53
HIGH
34.49
LOW
33.28
VOLUME
3.94M
TURNOVER
--
52 WEEK HIGH
170.47
52 WEEK LOW
29.25
MARKET CAP
12.91B
P/E (TTM)
-3.6087
1D
5D
1M
3M
1Y
5Y
1D
Stocks to Watch Monday: Domino's, Berkshire Hathaway; Alibaba
The Wall Street Journal · 5h ago
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Benzinga · 5h ago
Weekly Report: what happened at MRNA last week (0217-0221)?
Weekly Report · 6h ago
Notable healthcare headlines for the week: UnitedHealth, Moderna, Sanofi in focus
Seeking Alpha · 1d ago
Moderna’s 2024 Struggles: Navigating Commercial Challenges and Market Competition in the Vaccine Industry
TipRanks · 2d ago
Moderna Inc. Stock Climbs 5.3%, Outperforms Competitors
Dow Jones · 2d ago
3 Biotech/Healthcare Names Under $10 I Am Buying Now
Seeking Alpha · 2d ago
Noteworthy Friday Option Activity: ABR, INOD, MRNA
NASDAQ · 2d ago
More
About MRNA
More
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Recently
Symbol
Price
%Change

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.